About AnaSpec
AnaSpec is a company based in Fremont (United States) founded in 1993 was acquired by Eurogentec in October 2009. The company has 56 employees. AnaSpec operates in a competitive market with competitors including Sai Life Sciences, PrognomiQ, PreOmics, Vivostat and Acies Bio, among others.
- Headquarter Fremont, United States
- Employees 56
- SectorsHealthcare
- Website anaspec.com/en
- Social LinkedIn X Facebook
- Acquired by Eurogentec (Oct 2009)
- Legal Name Anaspec, Inc.
- Investors
- Employee Count56
- Acquired byEurogentec
(Oct 2009)
Investors in AnaSpec
AnaSpec has secured backing from 1 investor. Prominent investors backing the company include Eurogentec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. | 1985 | eurogentec.com | Seraing, Belgium |
Investor details for AnaSpec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AnaSpec
4 people are tracked at AnaSpec (3 in leadership, 1 in team); the tracked headcount is 56.
| Name | Role | Group |
|---|---|---|
Frank Hong | CEO | Leadership |
Anita Hong | President | Leadership |
Terry-Anne Andrews | Director Human Resources, G&a | Leadership |
Paula Flores | Human Resources Generalist | Team |
Complete people profiles for AnaSpec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AnaSpec
2 dated milestones of AnaSpec across 16 years, from founding to its latest funding, stage changes and deals.
- Founded AnaSpec is founded.
- Exit Acquired by Eurogentec.
Competitors of AnaSpec
AnaSpec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, PrognomiQ, PreOmics, Vivostat and Acies Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| preomics.com | 2014 | Munich, Germany | $19.14M | 22 | Reagents and instruments for proteomics research are supplied by PreOmics. | |
| vivostat.com | 2001 | Alleroed, Denmark | $12.89M | 9 | On-site fibrin sealant preparation systems are developed and provided. | |
| aciesbio.com | 2006 | Ljubljana, Slovenia | – | – | Provider of drug discovery and development services to pharmaceutical, biotech, and food industries | |
| leniobio.com | 2016 | Dusseldorf, Germany | $13.01M | 18 | Kits for cell-free eukaryotic protein expression are provided. | |
| acrobiosystems.com | 2016 | Newark, United States | – | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. | |
| anshlabs.com | 2010 | Webster, United States | – | 33 | Immunoassay reagents and kits are developed for life science research. | |
| personalchemistry.com | 1998 | Uppsala, Sweden | $50.46M | – | Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. |
Detailed competitors of AnaSpec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AnaSpec
The website of AnaSpec (anaspec.com) receives about 30.1K visits a month.
- Monthly visits30.1K
▲ 23.3% vs previous month
Websites whose visitors overlap most with AnaSpec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
aveslab.com | aveslab.com | 100% | – | – | – |
| prospecbio.com | 97% | 53.2K | #651,600 | View details | |
| abcam.com | 95% | 602.8K | #91,958 | View details | |
| phoenixpeptide.com | 93% | 102.4K | #300,152 | View details | |
| meridianlifescience.com | 90% | – | #11,146,867 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for AnaSpec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to AnaSpec
10 companies that operate in the same segment as AnaSpec (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AnaSpec
AnaSpec was founded in 1993.
AnaSpec is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Frank Hong is the current CEO of AnaSpec.
AnaSpec has 56 employees.
Integrated proteomic and genomic solutions for life science research are offered by AnaSpec, founded in 1993 and based in Fremont, United States. Biochemicals, detection reagents, antibodies, assay kits, oligonucleotides, and qPCR products are included in the portfolio for basic research, high-throughput screening, and drug discovery. Custom services such as peptide synthesis, antibody production, assay development, and oligonucleotide synthesis are provided.
AnaSpec's top competitors include Sai Life Sciences, PrognomiQ and LenioBio.
AnaSpec has 1 investor. Key investors include Eurogentec.
AnaSpec operates through Anaspec, Inc..
Yes. AnaSpec was acquired by Eurogentec in October 2009.